These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3132766)

  • 1. A comparison of cyclosporine, donor-specific transfusion, and antilymphocyte serum suppression of skin, heart, and fetal pancreatic islet allograft rejection in mice.
    Mason A; Mottram PL; Mirisklavos A; Clurne GJ; Mandel TE
    Transplantation; 1988 Jun; 45(6):1155-7. PubMed ID: 3132766
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple-combination therapy with cyclosporine, antithymocyte serum, and silica in pancreatic islet xenografting.
    Kanehiro H; Nakano H; Nakajima Y; Segawa M; Murao Y; Nakagawa K; Shiratori T
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1276-8. PubMed ID: 2856271
    [No Abstract]   [Full Text] [Related]  

  • 3. Postoperative bone marrow infusions with cyclosporine, silica, and antilymphocyte serum in rat islet allografts.
    Barneo L; Field MJ; Esteban MM
    Transplant Proc; 1990 Apr; 22(2):859-60. PubMed ID: 2158178
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of antilymphocyte serum on crude pancreatic islet allograft survival.
    Gotoh M; Maki T; Satomi S; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):576-7. PubMed ID: 3152704
    [No Abstract]   [Full Text] [Related]  

  • 5. Dissociation of skin and islet allograft rejection in antithymocyte globulin treated rats.
    Beyer MM; Lane FC; Friedman EA
    Transplant Proc; 1981 Mar; 13(1 Pt 2):815-8. PubMed ID: 6791336
    [No Abstract]   [Full Text] [Related]  

  • 6. Uselessness of donor-specific transfusions or prophylactic ALG with therapeutic cyclosporine doses in living related renal transplantation between one-haplotype matched pairs.
    Yamauchi J; Akiyama N; Sugimoto H; Tomikawa S; Mita K; Bekku Y; Ogawa Y; Imai T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1663-6. PubMed ID: 2652545
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
    Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of pancreatic islet allograft survival with ALS and donor bone marrow.
    Panijayanond P; Monaco AP
    Surg Forum; 1974; 25(0):379-81. PubMed ID: 4216093
    [No Abstract]   [Full Text] [Related]  

  • 9. Mouse skin allograft model for study of pregraft blood transfusion.
    Maki T; Okazaki H; Wood ML; Monaco AP
    Transplant Proc; 1982 Jun; 14(2):394-6. PubMed ID: 7051485
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental pancreas allograft rejection: correlation between histologic and functional rejection and the efficacy of antirejection therapy.
    Schulak JA; Drevyanko TF
    Surgery; 1985 Aug; 98(2):330-7. PubMed ID: 3895543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful allografts of pancreatic islets in diabetic rabbits after donor-specific blood transfusion and antilymphocyte serum treatment.
    Jolley WB; Knierim K; Hinshaw DB; Ham JM; Hinshaw DB
    Transplant Proc; 1982 Jun; 14(2):413-4. PubMed ID: 6810523
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of canine renal and islet transplantation with cyclosporine: assessment of islet immunogenicity.
    Kneteman NM; Evans MG; Cattral MS; Warnock GL; Rajotte RV
    Transplant Proc; 1989 Apr; 21(2):3366-7. PubMed ID: 2496506
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac transplantation in the sixth decade of life.
    Szentpetery S; Thames M; Hanrahan J; Morris J; Lower RR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2492-4. PubMed ID: 3079089
    [No Abstract]   [Full Text] [Related]  

  • 14. Survival and function of islet allografts in outbred mice.
    Simeonovic CJ; Prowse SJ; Lafferty KJ
    Transplant Proc; 1986 Apr; 18(2):316-8. PubMed ID: 3083546
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lymphocyte subpopulations in peripheral blood in the diagnosis of heart rejection in patients treated with cyclosporin A].
    Amengual MJ; Abadal ML; Cladellas M; Ballester M; Obrador D; Agustí M; Rodríguez JL
    Rev Esp Cardiol; 1987; 40 Suppl 2():41-4. PubMed ID: 3331803
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of donor strain blood and ALS therapy on pancreatic islet allograft survival in the rat.
    Selawry HP; Cohen HL; Mui MM
    Diabetes; 1981 Nov; 30(11):947-50. PubMed ID: 6795074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of antilymphocyte serum and cyclosporine on orthotopic small bowel allografts in the rat.
    Diflo T; Shaffer D; Maki T; Monaco AP
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):200-2. PubMed ID: 3258078
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac and skin heterograft rejection: suppression with antilymphocyte serum.
    Donawick WJ; Shaffer CF; Dodd DC; Buchanan JW; Fregin GF
    Transplant Proc; 1971 Mar; 3(1):551-3. PubMed ID: 4937937
    [No Abstract]   [Full Text] [Related]  

  • 19. [Echocardiographic study of the transplanted heart in patients treated with cyclosporin A].
    Abadal ML; Cladellas M; Ballester M; Obrador D; Ballester R; Pons-Lladó G
    Rev Esp Cardiol; 1987; 40 Suppl 2():45-51. PubMed ID: 3331804
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of posttransplant-administered peripheral blood lymphocytes for prolonging allograft survival in ALS-treated mice.
    Gozzo JJ; Monaco AP; De Fazio SR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):269-70. PubMed ID: 2650116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.